surmount-1 tirzepatide weight loss percent nejm 2022 SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs semaglutide 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Tirzepatide bests semaglutide for weight
Pay in 4 interest-free payments of $7.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19






















![Disintegrate [Alpha Edition] 257](https://cdn.shopify.com/s/files/1/0794/9162/9342/files/8712c49e-f171-4669-bed9-87575a37af11_dbfeba0a-b318-4b63-b759-a8a2211a11ca.png?v=1773401546)



